Zach Scheidt is pitching his Lifetime Income Report ($49) newsletter by hinting at some more big 5G winners — and while there’s probably not a whole lot new in the four stocks he’s teasing, since most of the 5G stocks have been discussed to death as we wait for the surge of next-generation profits to […]
Articles
- Most Relevant
- Most Recent
Sometimes it seems like investment newsletter teasers run in trends… last week we were inundated with “smart metal” pitches, this week the questions are pouring in about Doug Casey’s “Super Metal.” I guess we shouldn’t be surprised, so many newsletter ads try to implant a short little phrase in your head that harnesses their investing […]
InvestorPlace is certainly helping Nancy Zambell push the marketing message pretty hard for her new Buried Treasure Under $10 newsletter — who knows, if they keep this up we might be hearing as much from Nancy as we do from fellow InvestorPlace newsletter editors Louis Navellier, Robert Hsu and Tobin Smith. More power to her […]
This one’s from Christian DeHaemer for Material Profit, one of the “introductory” inexpensive newsletters from Taipan (on sale for $49 at the moment, apparently). This group is no stranger to your friendly neighborhood Gumshoe, but I don’t think I’ve looked at one from Material Profit before (I’ve looked at many from DeHaemer’s other services, most […]
On this bright and cheerful Monday we’re taking a look-see at a new entrant in the newsletter world — not only because it teases a couple intriguing investment ideas and promises great gains, as they all do, but because this is the first newsletter I’ve seen that is completely focused on India. Newsletters that look […]
Today we look into the teased “Gold-X” from Gerardo Del Real, who writes the Junior Mining Monthly newsletter and calls himself a “Texas gold expert” … his ad promises an easier way to get huge returns on little gold stocks while taking a lot less risk. “Gold-X” seems an odd name for a “secret” investing […]
Ian Wyatt is out with a new teaser promo for his $100K Portfolio service, and it’s all about a young company that’s growing rapidly and changing America in a substantial way … with a free new “highway” across the country. He pitches this secret stock using the same kind of language that several other growth-focused […]
I didn’t do anything with my portfolio this week, and I don’t think we’ve had significant news that changes my opinion about any of the stocks I wrote about in our Annual Review about ten days ago, so today I’ll just dig into a teaser pitch for your Friday File edutainment. Here’s the intro to […]
Carl Chen presented about Taiwan and China, presenting a Taiwanese stock and a Chinese stock. They think that China is still on the ascendancy, and that it has become too fashionable to talk about the failure of China, which has the longest existing human culture on the planet. Taiwan is a great place to look […]
This article was originally published on May 19, and the ad we’re covering has been heavily promoted over the past month, leading up to a big final push before yesterday’s supposed catalyst date of June 13, when Blanco (or his ad copywriter) was certain that Apple would announce some big news about “this tiny company”. […]
During the last few days when I was traveling to and reporting from the Value Investing Congress for the Irregulars (some great presentations, by the way, my notes from day one and day two are up now and I’m hoping to get some more thinking time in regarding these ideas soon), the most-requested teaser for […]
The idea that we’re finally going to enter an era of just and profitable growth in Africa (or at least, sustainable growth) has been around for a long time, and it’s been wrong for a long time, as Africa has arguably been subject to more exploitation, poverty, and human suffering than your average continent over […]
The response was pretty overwhelmingly positive when I started sending out those “Trade Note” emails this week… so I’ll stick with it for a while, at least, and see how this goes. What does that mean? Same day buy/sell notes about my Real Money Portfolio will be sent to the Irregulars going forward, in hopes […]
It’s been a little while since we dug into an Oxford Club promo, so this latest one that uses the eventual Facebook IPO as a hook caught my attention … in exchange for signing up for a membership in this particular club, they say you’ll “learn everything about making money from the ‘Facebook Effect.’” No, […]
Today, for our Friday pleasure, I thought I’d dig into a teaser for a newsletter that you can’t subscribe to right now even if you want to — how sexy and exclusive is that?! Actually, the teaser came out in a very abbreviated and clue-light form in an ad for the “re-opening” of a Motley […]
The idea that we’re finally going to enter an era of just and profitable growth in Africa (or at least, sustainable growth) has been around for a long time, and it’s been wrong for a long time, as Africa has arguably been subject to more exploitation, poverty, and human suffering than your average continent over […]
I haven’t written about a biotech teaser pick or about any of the Casey newsletters for quite a while, so this one that many readers sent in recently looked like a fine target for the Thinkolator today … The pitch is from Alex Daley, the “Chief Technology Investment Strategist” for Casey Research, and he’s trying […]
I was just puttering around this morning, trying to decide which ebullient and/or egregious teaser ad to focus on, when a new one came rolling in across the virtual transom … and it looked like just the thing to wake a Gumshoe up, so let’s dig in! The ad is from Horacio Marquez for his […]
Today, for our Friday pleasure, I thought I’d dig into a teaser for a newsletter that you can’t subscribe to right now even if you want to — how sexy and exclusive is that?! Actually, the teaser came out in a very abbreviated and clue-light form in an ad for the “re-opening” of a Motley […]
[Ed. Note: Dr. KSS writes about medicine and biotech for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] Conclusion of a Series on Pain [This column is dedicated to recovery from a recent cancer diagnosis of a stuff-of-legend friend whose life I cherish. She recently […]
Today we’re releasing an old Friday File for all of our free readers (and as a reminder for any Irregulars who missed it the first time around) — this ad has been running off and on for a long time, but we covered it on July 10 and the article below is not updated. The […]
Apparently Apple had some sort of news this week, and I guess the Federal Reserve is supposed to do something next week, eh? Well, there are thousands of market pundits who will tell you all about those things — and dozens who will tell you that the world is going to start coming to an […]
It’s been a heckuva week, eh? I have no idea whether this is really the “capitulation” washout that so many investing pundits have been looking for, or whether we’ll keep falling on Monday or will bounce back after the week ended so roughly, but I do have a couple thoughts to share with you about […]
A few relatively brief things for you today — updates on the flailing ICON and the high-yield MPW, and a few thoughts on “macro” panics in the market. First, the ugly — checking in on Iconix (ICON), which I last looked at a few months ago. The stock has gotten cut in half just since […]
I’ve got no shortage of possible topics to write about after a couple weeks respite — the teasers didn’t stop flowing while I was gone, and the hyperbole hasn’t been turned down for the sultry days of summer — but the one that’s been requested most has been the “Einstein’s Space Energy” pitch from Dr. […]
I’ve got a teaser pitch to solve for you, dear Irregulars — it’s from Roger Williams at Wall Street Daily, pitching his True Alpha letter by hinting at the stocks he thinks can double tomorrow in the “Penny Stock Index.” But first, a quick update on Criteo… A couple folks called yesterday’s (perhaps brief) crumpling […]
Pain management is a huge market in the medical world, as you’re no doubt aware — and buckets of money are pouring down on the many, many little biotech stocks who are trying to develop new pain medications, or to tweak existing medications to make them safer or less likely to be abused. So it’s […]
I couldn’t resist pulling this one out of the bin in the basement — the teaser ad came across my screen several times this week, which probably means that the Oxford Club folks are mailing it pretty heavily again…. and the ad they’re sending out is pretty much exactly, as far as I’ve been able […]
This article was originally published on August 13, 2013, around the time this teaser ad pitch was first circulated. The ad is still largely the same today and is circulating heavily again, and it is clearly still teasing the same company, so we’re just re-posting this article for all our newer readers who have questions… […]
Nothing beats a time machine for getting rich — if we learned nothing else from Back to the Future 2, we at least know that. So what is this “Time Machine” stock the Motley Fool folks have been touting? It’s not about going back in time and betting on football games with the benefit of […]
So far this year, one pundit’s pitch for the “top technology stock of 2015” has worked out well (that was Navellier’s tout of MEI back in January) — so perhaps that inspired a few readers to send a different pundit’s take on the same prognostication my way. Jim Pearce is pitching Investing Daily’s newish Smart […]
Investment advisory focusing on technology trends, they say they’re looking for “growth and income from the utility stocks of the future.”
[Ed. Note: Dr. KSS writes about medicine and biotech for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] Conclusion of a Series on Pain [This column is dedicated to recovery from a recent cancer diagnosis of a stuff-of-legend friend whose life I cherish. She recently […]
[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. Enjoy!] Readers not familiar with Stock Gumshoe usually arrive wondering if the salivation provoked by stock promotional writers for certain companies is justified. […]
People can’t get enough of the “Internet of Things” and the role that plays in the “smart home” of the future (or perhaps the present), so we’ve gotten a few questions about David Dittman’s Jetsons spiel in recent weeks — particularly since we covered the first stock he was teasing but didn’t get to the […]
I’m going to keep it brief for you today — and we’re not going to have a formal “Idea of the Month” piece for October because, well, we’re at the end of October and I haven’t recently come across a new idea that’s compelling enough for me to argue you should own it. In some […]
Most of us are self-directed investors, for good or ill — you’re probably here because you like researching or trading stocks, and I obviously feel the same. But should we be trusting ourselves to manage our money? I know that sounds like a fatuous question — obviously, we should trust ourselves much more than we […]
I’m running late today and working on a few pieces that aren’t done yet, but I don’t want to leave our fabulous Gumshoe readers with nothing to think about… so let’s get a quick teaser solution out for you. The pitch is from David Dittman for his Utility Forecaster, the conservative, income-focused newsletter that was […]
Will This Unknown Boston Biotech Make Present Surgical Techniques Obsolete?[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. His topics, words and opinions are his own. Enjoy!] It’s the second reel of conspiracy film Shooter, and Mark Wahlberg, whom government schemers are trying to frame for assassination, has just been shot twice. In the back of a stolen FBI car, […]
During the last few days when I was traveling to and reporting from the Value Investing Congress for the Irregulars (some great presentations, by the way, my notes from day one and day two are up now and I’m hoping to get some more thinking time in regarding these ideas soon), the most-requested teaser for […]
Recent Comments
Hi everyone, I am a part time model with a business degree. Over the last 2 years i've had alot of financial success with modelling and wanted to do some…...
Dear Dr. KSS, Every day has been like Christmas on SG because of your giving the gift of yourself - your time, boundless medical, biochemical, biotech, and pharmaceutical knowledge, smart…...
The most important Biblical financial principle is tithing; if I don't trust God enough to give back that 10% (which is His anyway), how can I expect Him to bless…...
How about this one? his Election Day Shocker Could Fund Your Retirement By Sandy Franks, Executive Director, Smart Investing Daily Dear Reader, Forget Romney and Obama... I'm writing to you…...
Shoeman has anyone done anything on currency x which is a secret account that is set aside for all us to draw from? Its touted by The League of Power…...
I'm waiting to hear from Stock Gumshoe on this one, please! As always, the pitch on this one is fear driven, based on some true things and some embelleshment along…...